Allendale Investigational Review Board (airb)

Name

Allendale Investigational Review Board (airb)

Legal name

Allendale Investigational Review Board

Website

https://allendaleirb.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

IRB / Clinical Research Ethics Review Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight) (HLAJACAG)

akta.pro secondary industry

Research Administration & Compliance (Sponsored Programs, IRB/REB) (EDADAKAH)

Keywords

• IRB review services
• Clinical protocol review
• Human subjects research
• FDA regulatory compliance
• Independent ethics review

Headquarters

HQ city

Old Lyme

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. IRB Review Services: The company generates revenue through providing clinical protocol review services. Services include Full Board Review, Rush Full Board Review, Specially Convened Review, Expedited Review, Continuing Review, and Amendments. The revenue model is likely based on per-review fees or subscription arrangements for ongoing research oversight.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Allendale Investigational Review Board (AIRB) is an independent IRB that reviews and approves clinical research protocols involving human subjects. The portfolio includes Full Board Review, Rush Full Board Review, Specially Convened Review, Expedited Review, Continuing Review, and Amendments, with reviews typically completed within one week and often within the same business day. Services are sold to pharmaceutical, medical device, dietary supplement, consumer product, and personal care product companies, as well as CROs, under FDA 21 CFR 50 and 56, EPA, and CPSC standards.

Product overview

The Allendale Investigational Review Board (AIRB) offers a suite of IRB review services for clinical research protocols. The core portfolio includes Full Board Review (weekly Thursday meetings with same-day results), Rush Full Board Review (for missed deadlines), Specially Convened Review (24-hour urgent reviews), Expedited Review (same-day minimal risk reviews), Continuing Review (annual and interval reviews), and Amendments processing. The company also provides referrals to Regulatory and Technical Associates for quality and regulatory consulting. All services are designed for rapid turnaround, often completing within the same week or one business day.

Differentiator

Problem solved

Functional benefit

Products and services

• Full Board Review Comprehensive review of research protocol submissions conducted during the weekly Thursday board meeting, with results reported by noon Thursday. Designed for pharmaceutical, medical device, dietary supplement, consumer product, and personal care product companies conducting clinical research involving human subjects.
• Rush Full Board Review Expedited full board review for submissions missed from the standard Monday deadline, due by 9pm EST Tuesday for Thursday review with results reported by noon Thursday.
• Specially Convened Review Urgent full board review conducted outside the standard Thursday meeting schedule, completed and results reported within 24 hours upon request, for time-sensitive research protocols.
• Expedited Review Review process for research presenting no more than minimal risk, conducted same business day per OHRP Guidance categories.
• Continuing Review Periodic review and approval of all non-exempt research projects at intervals appropriate to degree of risk, not less than annually, completed in 1 business day.
• Amendments Review and approval of amendments to currently approved research prior to implementation, except when necessary to eliminate immediate hazards to human subjects, completed in 1 business day.

Quantifiable outcome

• Protocol reviews completed same week, often same business day
• +5 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Regulatory and Technical AssociatesminorImplementation/ SI/ Consulting PartnerAIRB refers clients seeking Quality or Regulatory consulting support to Regulatory and Technical Associates. This is a referral relationship for specialized consulting services beyond IRB review.

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• IntegReview IRB: IntegReview is an AAHRPP-accredited independent central IRB providing protocol review services to pharmaceutical, biotech, and medical device sponsors. Directly comparable to AIRB in core service offering and target customer base.
• Sterling IRB: Sterling IRB is an AAHRPP-accredited independent IRB providing central IRB services for pharmaceutical, device, and CRO research. A direct peer in scale and service offering to AIRB, targeting similar sponsor and CRO clients.
• WCG (WIRB-Copernicus Group): WCG owns WIRB-Copernicus Group, one of the largest independent IRBs serving pharmaceutical and device sponsors globally. Directly comparable core service (central IRB review for human subjects research) but at significantly greater scale with technology-enabled workflows.
• BRANY (Biomedical Research Alliance of New York): BRANY operates an independent IRB serving academic medical centers, hospitals, and sponsors with central IRB review services. Directly comparable to AIRB in service scope (human subjects research review for clinical trials) though with stronger academic-center orientation.
• New England IRB: New England IRB is an independent central IRB providing protocol review services for clinical research. A directly comparable peer in independent, sponsor-facing IRB services with similar study-type scope.
• BioMedical Research Alliance of New York (BRANY) IRB: Already listed; removed to avoid duplication.
• Advarra: Advarra is a leading independent IRB provider (formed by the merger of Quorum Review IRB and Schulman IRB) offering central IRB review, IBC services, and research compliance technology. Directly comparable to AIRB as a central IRB serving pharmaceutical, medical device, and CRO clients with similar protocol review services.
• Chesapeake IRB (now Advarra): Chesapeake IRB (acquired by Advarra) was an AAHRPP-accredited central IRB serving Phase I-IV studies across pharma, device, and CRO clients. Comparable to AIRB in independent central IRB review services before its acquisition.
• Copernicus Group IRB: Copernicus Group IRB (now part of WCG) historically operated as an independent central IRB focused on ethical review of human-subjects research. Directly comparable to AIRB's central IRB service model for sponsors and CROs.

Emerging players

• Solutions IRB: Solutions IRB is a smaller, newer independent IRB offering central IRB services to research sponsors. Comparable to AIRB as a competing independent IRB with similar service offerings, though less established.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/allendale-investigational-review-board-airb

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allendale Investigational Review Board (airb)